Novo Nordisk: Top Technology Areas As to be expected, the majority of Novo Nordisks patent filings falls under A61K (medical, dental, and hygiene preparations), A61P (therapeutic activity of chemical compounds), and C07K (peptides)
Pipeline drugs, defined as pharmaceuticals for chronic weight management in development that have not yet been approved for clinical use, were included in the narrative review if human trial data were publicly available with sufficient information on the drugs time of development, clinical phase, MOA, dosing information, and reporting on weight loss outcomes
"Therefore, it is not possible to establish a cause-effect relationship between the products and the adverse event in question."
The choice between them depends on individual patient factors not just average trial results
Increasing the sample size will enhance the applicability of the findings